{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:11:03Z","timestamp":1777356663302,"version":"3.51.4"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:p>OBJECTIVES. Meningococcal disease continues to result in substantial morbidity and mortality in children, but there is limited recent surveillance information regarding serogroup distribution and outcome in children in the United States. The objective of this study was to collect demographic, clinical, laboratory, and outcome information for infants and children who had Neisseria meningitidis infections of various serogroups and were cared for in 10 pediatric hospitals.<\/jats:p>\n               <jats:p>METHODS. Investigators at each of the participating hospitals identified children with meningococcal infections and collected demographic and clinical information using a standard data form. Meningococcal isolates were sent to a central laboratory for serogrouping by slide agglutination and penicillin susceptibility.<\/jats:p>\n               <jats:p>RESULTS. From January 1, 2001, through March 15, 2005, 159 episodes of systemic meningococcal infections were detected. The greatest numbers of children were younger than 12 months (n = 41) or were 12 to 24 months of age (n = 22). Meningitis was the most common clinical manifestation of disease accounting for 112 (70%) cases; 43 (27%) children had bacteremia only. Children who were younger than 5 years (17 of 102) were significantly less likely to require mechanical ventilation than children who were 5 to 10 years of age (12 of 24) or children who were older than 10 years (13 of 33). Overall, 55 (44%) isolates were serogroup B, 32 (26%) were serogroup C, and 27 (22%) were serogroup Y. All but 1 isolate (intermediate) were susceptible to penicillin. The overall mortality rate was 8% (13 of 159) but was greater for children who were \u226511 years of age (7 [21.2%] of 33) than for children who were younger than 11 years (6 [4.8%] of 126). Unilateral or bilateral hearing loss occurred in 14 (12.5%) of 112 children with meningitis.<\/jats:p>\n               <jats:p>CONCLUSIONS. The morbidity and the mortality of meningococcal infections are substantial. With the recent licensure of meningococcal conjugate vaccines, our baseline trends in meningococcal disease can be compared with those seen after widespread vaccination to assess the success of routine immunization.<\/jats:p>","DOI":"10.1542\/peds.2006-0281","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T17:04:22Z","timestamp":1159808662000},"page":"e979-e984","source":"Crossref","is-referenced-by-count":85,"title":["Multicenter Surveillance of Invasive Meningococcal Infections in Children"],"prefix":"10.1542","volume":"118","author":[{"given":"Sheldon L.","family":"Kaplan","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon E.","family":"Schutze","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.D.","family":"Leake","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital San Diego, San Diego, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Barson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ohio State University College of Medicine and Public Health, Columbus, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha B.","family":"Halasa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie L.","family":"Byington","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Woods","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina Q.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill A.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen R.","family":"Wald","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward O.","family":"Mason","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,10,1]]},"reference":[{"key":"2021120822421740600_R1","unstructured":"Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. MMWR Recomm Rep.\u20082005;54(RR-7):1\u201321"},{"key":"2021120822421740600_R2","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Prevention and control of meningococcal disease: recommendations for the use of meningococcal vaccines in pediatric patients. Pediatrics.\u20082005;116:496\u2013505","DOI":"10.1542\/peds.2005-1314"},{"key":"2021120822421740600_R3","doi-asserted-by":"crossref","unstructured":"Stovall SH, Schutze GE. Meningococcal infections in children from Arkansas. Pediatr Infect Dis J.\u20082002;21:366\u2013370","DOI":"10.1097\/00006454-200205000-00003"},{"key":"2021120822421740600_R4","doi-asserted-by":"crossref","unstructured":"Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J.\u20081996;15:967\u2013979","DOI":"10.1097\/00006454-199611000-00009"},{"key":"2021120822421740600_R5","doi-asserted-by":"crossref","unstructured":"Pastor P, Medley FB, Murphy TV. Meningococcal disease in Dallas county, Texas: results of a six-year population-based study. Pediatr Infect Dis J.\u20082000;19:324\u2013328","DOI":"10.1097\/00006454-200004000-00012"},{"key":"2021120822421740600_R6","doi-asserted-by":"crossref","unstructured":"Wang VJ, Kuppermann N, Malley R, et al. Meningococcal disease among children who live in a large metropolitan area, 1981\u20131996. Clin Infect Dis.\u20082001;32:1004\u20131009","DOI":"10.1086\/319595"},{"key":"2021120822421740600_R7","doi-asserted-by":"crossref","unstructured":"Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal\/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomized trial. RBPI21 Meningococcal Sepsis Study Group. Lancet.\u20082000;356:961\u2013967","DOI":"10.1016\/S0140-6736(00)02712-4"},{"key":"2021120822421740600_R8","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2005:M100\u2013S15"},{"key":"2021120822421740600_R9","doi-asserted-by":"crossref","unstructured":"Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. JAMA.\u20081999;281:1906\u20131910","DOI":"10.1001\/jama.281.20.1906"},{"key":"2021120822421740600_R10","doi-asserted-by":"crossref","unstructured":"Shepard CW, Rosenstein NE, Fischer M; Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990\u20131999. Pediatr Infect Dis J.\u20082003;22:418\u2013422","DOI":"10.1097\/01.inf.0000066876.77453.04"},{"key":"2021120822421740600_R11","doi-asserted-by":"crossref","unstructured":"Kaplan SL, Mason EO Jr, Wald ER, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J.\u20082002;21:141\u2013147","DOI":"10.1097\/00006454-200202000-00011"},{"key":"2021120822421740600_R12","doi-asserted-by":"crossref","unstructured":"Edwards MS, Baker CJ. Complications and sequelae of meningococcal infections in children. J Pediatr.\u20081981;99:540\u2013545","DOI":"10.1016\/S0022-3476(81)80250-8"},{"key":"2021120822421740600_R13","doi-asserted-by":"crossref","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992\u20131996. J Infect Dis.\u20081999;180:1894\u20131901","DOI":"10.1086\/315158"},{"key":"2021120822421740600_R14","doi-asserted-by":"crossref","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med.\u20082001;344:1378\u20131388","DOI":"10.1056\/NEJM200105033441807"},{"key":"2021120822421740600_R15","unstructured":"Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network. Neisseria meningitidis, 2004-provisional. Available at: www.cdc.gov\/ncidod\/dbmd\/abcs\/survreports\/mening04prelim.htm. Accessed January 17, 2006"},{"key":"2021120822421740600_R16","doi-asserted-by":"crossref","unstructured":"Canica M, Dias, R, Nunes B, Carvalho L, Ferreira E, the Meningococci Study Group. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility. J Med Microbiol.\u20082004;53:921\u2013925","DOI":"10.1099\/jmm.0.45556-0"},{"key":"2021120822421740600_R17","unstructured":"Wong VK, Hitchcock W, Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J.\u20081989;8:224\u2013227"},{"key":"2021120822421740600_R18","doi-asserted-by":"crossref","unstructured":"Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957\u20131987. Pediatr Infect Dis J.\u20081989;8:8\u201311","DOI":"10.1097\/00006454-198901000-00003"},{"key":"2021120822421740600_R19","doi-asserted-by":"crossref","unstructured":"Barton P, Kalil AC, Nadel S, et al. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics.\u20082004;113:7\u201317","DOI":"10.1542\/peds.113.1.7"},{"key":"2021120822421740600_R20","unstructured":"Eisenberg P. Re: Discontinuation of study F1K-MC-EVBP, investigation of the efficacy and safety of Drotrecogin Alfa (activated) in pediatric severe sepsis [letter]. Available at: pedsccm.wustl.edu\/Research\/EVBP_letter.pdf. Accessed July 5, 2005"},{"key":"2021120822421740600_R21","doi-asserted-by":"crossref","unstructured":"Trotter CL, Andrew NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet.\u20082004;365:365\u2013367","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"2021120822421740600_R22","doi-asserted-by":"crossref","unstructured":"Ramsay M, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C vaccination ini England: database analysis. BMJ.\u20082003;326:365\u2013366","DOI":"10.1136\/bmj.326.7385.365"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/e979\/1115092\/zpe0100600e979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/4\/e979\/1115092\/zpe0100600e979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:30:45Z","timestamp":1639017045000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/4\/e979\/69038\/Multicenter-Surveillance-of-Invasive-Meningococcal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,10,1]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0281","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}